Skip to content

Food and Drugs Act

R.S.C., 1985, c. F-27

In forceCurrent to September 30, 2026 History

Follow

Part I — Foods, Drugs, Cosmetics and Devices

Therapeutic Products

Section 21.301

Marginal note:Information — serious environmental risk

  •  (1) If the Minister believes that a therapeutic product may present a serious risk to the environment, the Minister may order a person to provide the Minister with information that is in the person’s control and that the Minister believes is necessary to determine whether the product presents such a risk.

  • Marginal note:Disclosure — serious environmental risk

    (2) The Minister may disclose confidential business information about a therapeutic product without notifying the person to whose business or affairs the information relates or obtaining their consent, if the Minister believes that the product may present a serious risk to the environment.

  • Marginal note:Disclosure —  protection of the environment

    (3) The Minister may disclose confidential business information about a therapeutic product without notifying the person to whose business or affairs the information relates or obtaining their consent, if the purpose of the disclosure is related to the protection of the environment and the disclosure is to

    • (a) a government;

    • (b) a person from whom the Minister seeks advice; or

    • (c) a person who carries out functions relating to the protection of the environment, including the assessment and management of risks to the environment.

  • Marginal note:Definition of government

    (4) In this section, government has the same meaning as in subsection 21.1(4).

  • 2023, c. 12, s. 65
.

Version in force since June 13, 2023

Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.